| mRNA |
Nilotinib |
CCLE |
pan-cancer |
AAC |
-0.25 |
5e-07 |
| mRNA |
AZD6244 |
CTRPv2 |
pan-cancer |
AAC |
-0.18 |
7e-07 |
| mRNA |
selumetinib:tretinoin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.18 |
8e-07 |
| mRNA |
selumetinib:navitoclax (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.18 |
1e-06 |
| mRNA |
PD318088 |
CTRPv2 |
pan-cancer |
AAC |
-0.16 |
3e-06 |
| mRNA |
YM-155 |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
6e-06 |
| mRNA |
NPK76-II-72-1 |
GDSC1000 |
pan-cancer |
AAC |
-0.13 |
8e-06 |
| mRNA |
selumetinib:UNC0638 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.16 |
9e-06 |
| mRNA |
OSI-906 |
CTRPv2 |
pan-cancer |
AAC |
-0.15 |
4e-05 |
| mRNA |
BMS-754807 |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
4e-05 |